1
|
Yan H, Kerns JK, Jin Q, Zhu C, Barnette MS, Callahan JF, Hay DWP, Jolivette LJ, Luttmann MA, Sarau HM, Ward KW, Widdowson KL, Wan Z. A Highly Convergent Synthesis of 2‐Phenyl Quinoline as Dual Antagonists for NK2 and NK3 Receptors. SYNTHETIC COMMUN 2006. [DOI: 10.1080/00397910500281234] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- Hongxing Yan
- a Department of Medicinal Chemistry , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Jeffrey K. Kerns
- a Department of Medicinal Chemistry , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Qi Jin
- a Department of Medicinal Chemistry , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Chongjie Zhu
- a Department of Medicinal Chemistry , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Mary S. Barnette
- b Department of COPD Biology , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - James F. Callahan
- a Department of Medicinal Chemistry , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Douglas W. P. Hay
- b Department of COPD Biology , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Larry J. Jolivette
- c Department of DMPK , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Mark A. Luttmann
- b Department of COPD Biology , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Henry M. Sarau
- b Department of COPD Biology , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Keith W. Ward
- c Department of DMPK , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Katherine L. Widdowson
- a Department of Medicinal Chemistry , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| | - Zehong Wan
- a Department of Medicinal Chemistry , Respiratory & Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals , King of Prussia , Pennsylvania , USA
| |
Collapse
|
2
|
Liu G, Fan Y, Carlson JR, Zhao ZG, Lam KS. Solution-phase synthesis of a 1,5-dialkylamino-2,4-dinitrobenzene library and the identification of novel antibacterial compounds from this library. JOURNAL OF COMBINATORIAL CHEMISTRY 2000; 2:467-74. [PMID: 11029172 DOI: 10.1021/cc000016l] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In this report we demonstrate that a 1,5-dialkylamino-2,4-dinitrobenzene small molecule library can be generated by a highly efficient solution-phase synthesis method. From this 2485-member library, a series of novel compounds with antibacterial activity were isolated. The significance of this report is that the synthetic scheme is extremely simple, with minimal number of liquid handling steps, and the solvents and reagents left in the final library preparation are fully compatible with cell-based assays.
Collapse
Affiliation(s)
- G Liu
- Department of Internal Medicine, UC Davis Cancer Center, Sacramento, California 95817, USA
| | | | | | | | | |
Collapse
|